Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.

Authors: Stoop, MP  Rosenling, T  Attali, A  Meesters, RJ  Stingl, C  Dekker, LJ  Van Aken, H  Suidgeest, E  Hintzen, RQ  Tuinstra, T  Van Gool, A  Luider, TM  Bischoff, R 
Citation: Stoop MP, etal., J Proteome Res. 2012 Aug 3;11(8):4315-25. doi: 10.1021/pr300428e. Epub 2012 Jul 25.
Pubmed: (View Article at PubMed) PMID:22768796
DOI: Full-text: DOI:10.1021/pr300428e

To identify response biomarkers for pharmaceutical treatment of multiple sclerosis, we induced experimental autoimmune encephalomyelitis (EAE) in rats and treated symptomatic animals with minocycline. Cerebrospinal fluid (CSF) samples were collected 14 days after EAE induction at the peak of neurological symptoms, and proteomics analysis was performed using nano-LC-Orbitrap mass spectrometry. Additionally, the minocycline concentration in CSF was determined using quantitative matrix-assisted laser desorption/ionization-triple-quadrupole tandem mass spectrometry (MALDI-MS/MS) in the selected reaction monitoring (SRM) mode. Fifty percent of the minocycline-treated EAE animals did not show neurological symptoms on day 14 ("responders"), while the other half displayed neurological symptoms ("nonresponders"), indicating that minocycline delayed disease onset and attenuated disease severity in some, but not all, animals. Neither CSF nor plasma minocycline concentrations correlated with the onset of symptoms or disease severity. Analysis of the proteomics data resulted in a list of 20 differentially abundant proteins between the untreated animals and the responder group of animals. Two of these proteins, complement C3 and carboxypeptidase B2, were validated by quantitative LC-MS/MS in the SRM mode. Differences in the CSF proteome between untreated EAE animals and minocycline-treated responders were similar to the differences between minocycline-treated responders and nonresponders (70% overlap). Six proteins that remained unchanged in the minocycline-treated animals but were elevated in untreated EAE animals may be related to the mechanism of action of minocycline.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 7243111
Created: 2013-05-03
Species: All species
Last Modified: 2013-05-03
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.